Ignite Creation Date:
2024-05-06 @ 1:26 PM
Last Modification Date:
2024-10-26 @ 1:14 PM
Study NCT ID:
NCT04028245
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2019-07-18
Brief Title:
A Study of Combination Spartalizumab and Canakinumab in Patients With Localized Clear Cell Renal Cell Carcinoma
Sponsor:
Organization:
Columbia University